Mechanistic studies have demonstrated that TRIP13 directly binds to EGFR and regulates the EGFR signaling pathway, thereby influencing the stage, lymph node metastasis, distant metastasis, and survival rate of patients with advanced BC. Here, EGFR is linked to breast cancer.